Skip to content

Public FDA record

Z-0138-2027: Grafton" DBM and Grafton Plus" DBM contain demineralized human bone tissue combined with an inert additiv

Recall record Z-0138-2027 for Medtronic Sofamor Danek USA Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0138-2027
Company in FDA record
Medtronic Sofamor Danek USA Inc
FDA classification date
Oct 9, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Medtronic identified through donor record review that the donor for Medtronic batch A62881 did not meet all Medtronic donor eligibility requirements related to the presence of microbial organisms. While the batch passed finished product sterility testing Medtronic is retrieving any unused product manufactured from the donor tissue. Donor bone tissue tested positive for Clostridium butyricum and while tissue did undergo gamma radiation, if implanted, there is a possibility of clostridium infection.

Source facts

Action
On 8/12/2026, recall notices were mailed or emailed to customers who were asked to do the following: 1) Identify and quarantine any unused impacted product(s). 2) Return affected product(s) per the return instructions in the enclosed Customer Confirmation Form. If product was purchased directly from Medtronic please contact: rs.sdmrarequest@medtronic.com, 3) For patients already implanted with affected products, consider potential Clostridium infection if the patient presents with signs or symptoms of infection. If a patient develops an infection with clostridium at a remote site, evaluate the surgical site for potential infection. 4) Share this Field Safety Notice with all individuals within your organization who need to be aware of this action. If any impacted products have been transferred to another organization, please ensure that a copy of this notice is provided to that organization as well. 5) Complete and return the Customer Confirmation Form via email to neuro.quality@medtronic.com
Initiated
2026-08-12
Root cause
Process change control
Distribution
US Nationwide distribution in the states of OK, VA, CO, AR, FL, TX, MD, DE, IL, MI, KS, AL, GA.
Recall number
Z-0138-2027
Recall status
Open, Classified
CDRH record ID
222237
FDA classified
2026-10-09
Recall event number
99701

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗